Engineered Strain Mutations for Higher Tryptophan Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The production efficiency of L-tryptophan is low due to its long biosynthetic route, requirement for multiple precursors, and strong feedback inhibition, making it difficult for industrial strains to meet market demand, and existing metabolic engineering strategies fail to enhance production effectively.
Innovation Solution
An engineered strain is developed by modifying proteins unrelated to the main metabolic pathways, specifically introducing mutations in the pepD and fadR proteins, and using a mutagenesis system based on cytidine deaminase and T7 RNA polymerase fusion to accelerate mutagenesis, combined with genome sequencing for productivity improvement.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If rational modification of metabolic pathways is applied, then production efficiency is improved, but the complexity of metabolic network limits the effectiveness
Solution Approach 1:
The patent employs mutagenesis to induce point mutations in proteins unrelated to the main tryptophan biosynthetic pathway (specifically pepD and fadR proteins). This changes the parameters of auxiliary proteins rather than directly modifying the complex metabolic pathway, thereby improving tryptophan production while avoiding the limitations imposed by metabolic network complexity.
2Speed
If cytidine deaminase is expressed to induce mutations, then mutation rate increases, but known strategies cannot achieve rapid production enhancement
Solution Approach 1:
The patent uses cytidine deaminase as an intermediary mutagenic agent that incorporates into the genome and induces point mutations during DNA replication. This intermediary approach accelerates the mutation rate and enables rapid adaptive evolution, overcoming the limitation of traditional strategies that could not achieve rapid production enhancement despite increased mutation rates.
Solution Approach 2:
The patent implements adaptive evolution through multi-stage selection processes where mutant strains are screened based on tryptophan production performance. High-performing mutants are selected and subjected to further mutagenesis cycles, creating a feedback loop that continuously enhances production capacity. Genome sequencing provides feedback on mutation patterns to guide subsequent engineering efforts.
3Adaptability or versatility
If modifications are made to proteins unrelated to main metabolic pathways, then new production capabilities are discovered, but results are difficult to predict and regulate
Solution Approach 1:
The patent performs comprehensive genome sequencing and protein sequence analysis before and after mutagenesis to identify specific mutations in proteins like pepD and fadR. This preliminary characterization of mutation patterns enables better prediction of which mutations are beneficial, improving the ability to regulate and direct the mutagenesis process toward desired outcomes.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered strain achieves a 1.48-fold increase in tryptophan production and a 1.26-fold increase in glucose-to-tryptophan yield, reaching 62.38±5.80 g/L in a 5 L fermenter, enhancing industrial competitiveness.
Implementation Method 1
Inspired by the mutagenesis system based on the fusion of cytidine deaminase and T7 RNA polymerase, it is found that fusing cytidine deaminase with the a subunit of Escherichia coli RNA polymerase enables accelerated mutagenesis to levels that support efficient adaptive evolution in Escherichia coli
Data Source
AI summary
An engineered strain for improving tryptophan production and a construction method and use thereof are provided. By screening out a strain capable of tolerating high-concentration tryptophan and performing genomic sequencing and protein sequence analysis on the strain, it is found that certain proteins in the strain undergo point mutations and these mutations are capable of enhancing tryptophan production. To increase tryptophan production, protein sequences encoded by fadR or pepD genes in a parent strain are modified. These modifications result in an engineered strain with significantly higher tryptophan production compared to the parent strain. Under scaled-up production conditions, the tryptophan production reaches 62.38±5.80 g/L in a 5 L fermenter, with a glucose-to-tryptophan yield of 24.1%. Compared to an original strain, tryptophan production increases by 1.48-fold, and the glucose-to-tryptophan yield improves by 1.26-fold. The biological materials and its use belong to the technical field of molecular biology and possess broad practical application value.